LifeVantage 創立於2003年 美國股票上市公司--LFVN
Founded in 2003, LifeVantage is headquartered in Salt Lake City, Utah. LifeVantage is commited to helping people achieve healthy living through scientifically validated products and an attracative business opportunity. As a leader in the fight against oxidative stress by focusing primarily on Nrf2 activation, we want everyone to prosper and thrive, and we are committed to doing it in a way that brings a better quality of life to the world.
LifeVantage products were originally distributed through retail outlets across the nation but in 2009, to more effectively educate consumers about its products and as a way to bolster its sales, the company strategically transitioned into network marketing. We accomplish our goal of helping provide physical and financial prosperity for all in a fiscally responsible, profitable way that rewards and is in the best interests of all our constituents: product consumers, distributors, employees, shareholders, board members and future consumers and other constituents as well. Despite a sluggish economy, LifeVantage has seen unprecedented growth.
The LifeVantage Management team consists of President and CEO Douglas C. Robinson, CFO David Colbert, Chief Science Officer Dr. Darlene Walley, Chief Operating Officer Robert Urban, President of LifeVantage Network David Brown and Chief Network Officer Kirby Zenger. They and the rest of the LifeVantage family are passionately committed to their most important goal: a better of quality of life for all.
驚人高速成長中的LifeVantage
Lifevantage Corporation(美國股票上市公司--LFVN)成立於2003年,總部位於美國猶他州,在美國是一家保健品直銷公司,Protandim為公司的主力產品(膳食補充劑,抗氧化)及抗衰老護膚品(面霜)。
銷售區域主要分布在美國、日本、墨西哥、澳洲,銷售方式主要透過--網路營銷。
銷售區域主要分布在美國、日本、墨西哥、澳洲,銷售方式主要透過--網路營銷。
2012年Q4 財報成長 197% 美金4,460萬
|
Fiscal 2012 Full Year Highlights Compared to Fiscal 2011 Full Year Include
2011年比較,成長224% --> 一億2,620萬美金
- Net revenue increased 224% to $126.2 million;
- Operating margin increased to17.0% compared to 9.5%;
- Operating income grew 480% to $21.5 million; and
- Cash and cash equivalents grew to $24.6 million as of June 30, 2012 from $6.4 million as of the prior year-end.
LifeVantage五年來的股價成長圖
(只能說 太績優了 未來可期.... 請注意2009後的成長)
单击此处进行编辑.
Usana v.s LifeVantage
单击此处进行编辑.